Print PDF


Convergence of healthcare and technology creating new opportunities

Innovations directed to digital health are revolutionizing the healthcare industry. Startups and established companies alike are developing unconventional solutions—from wearables to genomics to personalized medicine—that help not only to identify and diagnose diseases, but also to predict, manage, and potentially prevent them. Such solutions are intended to drive down costs, while also improving patient care.

Consumers have access to an ever increasing number of affordable and portable devices designed to provide various metrics and details about personal health and lifestyle. Online services provide patients and consumers with access to data analytics and health information that was previously available only from a healthcare professional. In an increasingly connected world, this type of personal information can be invaluable in helping healthcare professionals provide higher levels of care to patients. At the same time that digital health technologies are allowing for the easy collection and sharing of information, additional technologies continue to help ensure the privacy and security of that information.

With the increasing availability of data, digital health companies are employing advanced analytical techniques to optimize the entire patient management and treatment pipeline. These technologies are affecting every aspect of healthcare, including insurance network design, patient management, access to medical devices and personal medical information, patient-physician communication systems, and non-traditional methods for managing personal health.

As modern medicine grows in complexity and moves beyond the capacity of human retention—there are thousands of diagnoses, drugs, and medical and surgical procedures available today—digital health technologies provide the necessary tools to advance the level of patient care and service.

Protecting investments in the digital-health space

Digital health companies are leveraging advances across multiple technology disciplines to build their products. These convergences necessitate a multidisciplinary approach for appropriately and adequately protecting the resulting intellectual property. This is where Finnegan excels. The scope and depth of Finnegan’s technical experience spans from the life sciences (biotechnology, pharmaceuticals, genomics, bioinformatics, medical devices), across computer and software technologies such as big data and cloud storage, to industrial manufacturing, nanotechnology, sensors, and other related fields. Our extensive experience positions us to understand both the science at the foundation of our clients’ IP assets and the relevant legal issues they face.

We also understand the legal nuances corresponding to these various technologies. Certain types of technologies can be more sensitive than others when it comes to specific legal aspects, so we work closely with clients to develop appropriate strategies for acquiring IP protection based on their core business goals, development speed, ease of market entry, market fluidity, changing alliances, ease of copying, and ease of enforcement. We also evaluate current industry trends, pending legislation and case law, potential product and industry developments, and the effect of those developments on our clients’ IP position. We then advise them on how best to protect their innovations through patents, copyrights, and trade secrets, and we guide them around the barriers created by others. Our goal is to efficiently and effectively identify and secure those protections that will provide the most value and benefit to our clients.

Deep knowledge of both technology and law

In this rapidly evolving space, it is not enough to simply know the law. Backed by 350 professionals focused on intellectual property, Finnegan has a distinct advantage in assisting clients with protecting and leveraging digital health innovations. More than 75 of our professionals have Ph.D.’s, and more than 100 have Masters of Science degrees. Our talent pool includes former in-house counsel, patent examiners, researchers, and engineers in disciplines involving:

  • Genomics
  • Biotechnology and therapeutics
  • Implantable and wearable devices
  • Nanosensors and the Internet of Things (IoT)
  • Cognitive computing
  • Big data and bioinformatics
  • Secure data storage and transmission
  • Web-based software applications
  • Augmented and virtual reality
IP strategic planning and services

Finnegan helps digital health innovators develop comprehensive and tailored IP strategies to meet their needs. We counsel them on the full range of IP issues:

  • Developing and managing a comprehensive patent portfolio by obtaining patents in the United States and abroad.
  • Monetizing patent portfolios to generate additional revenue streams.
  • Analyzing the competitive landscape and advising clients regarding the freedom to develop new products.
  • Writing opinions and providing ongoing counseling for new and evolving technologies.
  • Conducting due diligence investigations.
  • Negotiating license agreements that provide the freedom to get their products to the market.
  • Protecting against infringement through litigation or other dispute resolution options.
  • Providing trademark protection and counseling.